Although the number of studies on the economic impact of palliative care (PC) is growing, the great majority report costs from North America.
Introduction
Palliative Care (PC) improves the quality of care at the end of life, reduces symptoms and leads to a higher patient, family, and physician satisfaction when compared to curative treatments on regular wards. [1] [2] [3] The cost impact of PC has been explored in different contexts, but more often comparing hospital costs of PC vs. UC. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] The majority of these studies have focused on average daily costs and total costs (see appendix I). [3] [4] [5] [6] [7] 9, [12] [13] [14] [15] Other studies focus on direct costs that can be completely attributed to medications, procedures, or services such as patient care supplies and medication. 3, 4, 11, 12, [15] [16] [17] [18] Of these, the majority report lower costs for PC than for UC. [3] [4] [5] [6] [7] 9, [11] [12] [13] [14] [15] [16] 18 In addition, some of the studies analyze individual cost components such as pharmacy, laboratory, imaging or intensive care unit (ICU) costs. 3, 5, 6, 11, 13, 15, 17 The majority of studies show a clear trend towards lower PC costs. Management, procedures or room costs are analyzed sporadically. 5, 15, 17 A deeper analysis of cost components such as detailed staff or catering costs, have not been examined to date. Since staff costs account for about 64.5 % of Swiss hospital revenues, it is surprising that none of the aforementioned studies performed in other countries have focused on this cost type. 19 In addition, there is a lack of European research assessing the cost impact of PC, since most studies originate in the United States (US) and thus, concentrate on a privately funded healthcare system. [3] [4] [5] [6] [7] [8] [9] [10] [11] [13] [14] [15] [16] [17] [18] Findings from the US cannot generally be transferred to a mixed private and socially funded health care system, as it exists in Switzerland and other countries.
There are several reasons why the examination of PC from an economic perspective is crucial: One of the main global challenges in the next years is to keep fundable healthcare systems. 2 As an example, Swiss healthcare expenditures have been rising every year since 1990 by about 2%. The relative share of healthcare expenditures on the Gross Domestic Product was 8% in 2010, whereas it grew to 12.1% in 2015. 20 Additionally, Switzerland has a short history of encouraging PC. While in the US 60% of the hospitals report the existence of a PC program, in Switzerland 7.8% of stationary institutions run a certified PC program. 13, [20] [21] [22] Finally, according to the Swiss Federal Statistical Office, in 2015 the proportion of the population aged 65 years and older was 18% and it is estimated that this share will increase to 26.4% in 2045. 24 Consequently, as the population ages and their needs become more complex, the greater need for PC will be inevitable. 25 In this study, we aimed to retrospectively analyze the cost impact of in-hospital PC with a particular focus on exploring which specific cost components drive the cost of PC. The majority of existing PC cost studies focus only on individual cost components. Therefore, this is the first study that gives a comprehensive overview of all occurred direct and indirect hospital costs.
Methods

Study Design
After receiving ethical approval (KEK-2017-00400), we performed a retrospective, observational cost analysis examining administrative and medical patient data from a large academic University hospital in Switzerland.
Sample Selection
We captured data from the last hospital admission of patients who died between January 1 st and December 31 st , 2015. Patients with dissent to further use of medical data (Humanforschungsgesetz -HFG) were excluded, as were perinatal deaths, deceased children (patients younger than 18 years of age), and patients who, according to the ICD-10, died due to an external cause, such as an accident or an injury. These deletions reduced the number from 976 to 780 cases. Lastly, after exclusion of ambulatory patients and patients with missing cost data, the final sample size included 746 patients (see Figure 1 ). All included patients were observed once.
We classified patients as receiving PC if their time in PC accounted for more than 25% of the last stay and they had either: a) inpatient care at the PC ward; or b) if the patient was seen and evaluated by the PC team after a PC consultation was requested by the attending physician, or c) if the treating team received recommendations from the PC team. All other patients were classified as UC, including those who had PC input for less than 25% of the last hospitalization. Primarily, our rationale for the 25% criteria was because in Switzerland referrals to PC occur rather late in the care trajectory, including during the last hospitalization. Therefore, in order to include late referrals that may still have obtained a meaningful contribution from during the last hospitalization, we chose 25% of PC involvement as the minimum. In the end, we included 642 patients in UC and 104 in PC.
Clinical and Financial Data
To gain a comprehensive financial overview of hospital costs, we required clinical and financial data from several sources (see Table 1 for an overview of all hospital databases employed).
We derived clinical data from the patient characteristics' database, which provides administrative information about, age, sex, death date, residency and marital status, as well as medical data such as main diagnoses, main treatments, Casemix-Index and cost weight.
The cost weight is an empirically determined relative weight describing the average treatment effort of a given group of patients. 26 The patient process database contains all inhouse movements of each patient, for instance patient movement from the emergency room (ER) to gastroenterology.
From the hospital's cost accounting system, we retrieved patient costs for each hospital day and for the entire admission period. The activity records database gives information about all services and items rendered including, staff activities, materials, laboratory and catering at the exact date and time when each activity occurred.
We retrieved the sum of the costs for each patient from the cost unit accounting database.
This database provides information about the costs per case and unit. For example, a patient generates an expense of CHF 2'500 in the surgery room. However, it does not have exact information on the corresponding date nor differentiates between performances given over a period of more than one day. For PC patients, costs arising before the PC intervention were not differentiated.
As the activity records database does not include a detailed list of delivered medication, we gathered data from all in-house medication databases, namely the databases of the regular ward, the ER, and of the ICU.
Development of Cost Matrix
Accessing and merging the seven different databases was necessary to obtain the required level of detail, and which allowed for a comprehensive overview of all direct and indirect hospital costs. While direct costs can be completely attributed to medications, procedures, or services, indirect costs are not directly related to any specific service and involve different departments. In terms of hospital care, direct costs include, inter alia, patient care supplies, medication, imaging, pharmacy as well as room and board costs. Hospital overhead costs, such as general hospital administration, cleaning or facility services as well as information technology, are more difficult to assign to a patient and, therefore, are considered to be indirect or shared costs. [27] [28] [29] In order to capture all relevant hospital costs, we thoroughly reviewed the existing literature (see Table 2 for an overview of all cost components used to date to explore cost differences between UC and PC and refer to Appendix I for a more detailed summary). Since the different cost components belong to different categories, we assigned the costs components to three different categories: total costs, cost types, and organizational units. The category "total costs" labels all cost components that describe total costs in general. The second group describes where certain costs arise, and thus, include organizational units of a hospital such as ICU and imaging. The category "cost types" summarizes the different kinds of costs.
We then matched the available hospital data with the already existing cost components from the literature. In order to get a comprehensive overview of all incurred hospital costs, we added organizational units and cost types. Since we also had detailed information on staff, we split this cost type into four sub-cost components (nursing, physician, therapist, and social counselling). Table 3 shows the developed cost matrix.
Data Analysis
Continuous and categorical patient characteristics are presented with mean and standard deviation (sd) or median and quartiles (lower, upper), and relative and absolute frequencies.
PC and UC groups were compared using Mann-Whitney-Wilcoxon or chi-squared tests for continuous and categorical variables.
The crude cost data (see appendix II) are presented with mean and standard deviation for each group and compared between PC and UC using linear regression with robust standard error. We used bootstrapping with 2'000 repetitions to correct for bias and calculate 95% confidence intervals (95% CI). 34 Cost data were adjusted using inverse probability weighting based on propensity scores. This method is used widely in observational studies to adjust for cofounding effects and to control for selection bias and has been shown to improve estimates of the effect of an intervention on costs. [30] [31] [32] We derived propensity scores through a logistic regression with "age", "marital status" (as binary variable, married yes/no), "insurance class", "primary diagnosis" and "location prior to entry" (e.g. home, other hospitals, psychiatric clinic) as covariates. For the inverse probability weighting, we used stabilized weights and calculated potential outcome means (POM) and average treatment effects (ATE) based on weighted linear regression. 32 P-values were derived using the biascorrected point estimate and the bootstrap standard errors with a normal approximation.
As a sensitivity analysis, we used generalized linear models with gamma distribution and loglink to fit the cost data. The estimated model coefficients are presented on the exponentiated scale and can be interpreted as mean per group and as mean ratio between groups. Crude estimates were calculated from intercept only models for each group and a model with group as covariate (see appendix V). The analysis was adjusted using inverse probability weighting by propensity scores as described above (see appendix III+IV).
To allow for international comparisons, instead of the 25% criteria to define PC exposure, we followed the 3-day criteria from admission followed by others 35 and performed further sensitivity analyses.
Results
Patient Characteristics
Patients in the PC group were younger than those in UC (64.7 years vs. 70.8 years, p<0.001). The majority were male and married. Over three quarters of patients from both groups had public insurance plans. Primary diagnoses differed between UC and PC significantly (p<0.001). More than half of UC patients (377, 59%) died of a cardiovascular disease followed by malignant neoplasms (108, 17%) while most of the PC patients died of malignant neoplasms (77, 74%) followed by cardiovascular diseases (12, 12%) . In UC, two thirds of patients (423, 66%) were admitted to the hospital from home and 193 (30%) from other hospitals, while within PC, 87 (84%) patients were admitted from home and only 10 (10%) from another hospital.
Admissions to the ER were significantly higher for UC patients (474, 74%) than for PC (62, 60%), as well as to the ICU, where 420 (65%) UC patients were admitted at least once, while only 27 (26%) PC patients were admitted there (p<0.001). Moreover, there was a significant difference in average length of stay of 8.8 days (p<0.001) with PC patients having longer stays (refer to Table 4 for patient characteristics).
Financial Analysis
All cost components: With respect to all cost components aggregated, total costs over the whole stay were relatively similar for PC (CHF 38'381, 95%CI 30'230 to 48'132) and UC patients (CHF 41'158, 95%CI 36'191 to 47'731) leading to a mean difference of CHF -2'777 with a wide 95% confidence interval (-12'713 to 8'506) that included 0 ( Table 5 ). Average daily costs for a PC patient were significantly lower (CHF -3'244, 95%CI -3'811 to -2'631) than for UC (Table 6 ). Table 5 and 6 show a clear trend that PC patients had lower total costs than UC patients in radiology (CHF -1'457, 95%CI -1'937 to -1'027), ICU (CHF -8'895 95%CI -12'734 to -5'772) and surgery (CHF -1'555, 95%CI -3'529 to 731). The same was true for average daily costs in the same organizational units. The opposite effect was observed for hotel costs (total costs CHF 1'701, 95%CI 1'204 to 2'272 and average daily costs CHF 16, 95%CI 1 to 33). Ward costs were lower in terms of average daily costs for PC than for UC patients (CHF -814 CHF, 95%CI -1'176 to -444), but were higher in terms of total costs (CHF 7'385 95%CI 596 to 14'785). Emergency room costs were similar in both groups.
Organizational units: The results presented in
Cost types:
The effect on total and average daily costs showed the same direction for catering, laboratory, material, other, pharmacy and room costs. Laboratory, material, pharmacy, and other costs were cheaper for PC patients, while the other costs showed the opposite trend (Table 5 and 6 ). Total patient management and staff costs were similar in both groups, whereas average daily costs were lower in PC.
Staff detail:
Nursing (costs per day: CHF 180, 95%CI -137 to 550; total costs: CHF 9'625, 95%CI 5'300 to 14'763), social counselling (costs per day: CHF 48, 95%CI 28 to 66; total costs: CHF 282, 95%CI 164 to 415) and therapist costs (costs per day: CHF 60, 95%CI 33 to 105; total costs: CHF 347, 95%CI 134 to 609) were higher for PC patients than for UC patients. The opposite effect was observed for physicians, who had lower average daily costs (CHF -1'644, 95%CI -2'177 to -1'139) and total costs (CHF -8'288, 95%CI -13'021 to -3'918) for PC patients compared to UC patients.
Sensitivity Analyses
The results remained similar when a generalized linear model with gamma distribution and log-link was used instead of the linear model (see appendix III-IV). Total costs were similar in both groups with a mean ratio of PC vs UC of 0.94 (95%CI 0.68 to 1.18), whereas costs per day were reduced in the PC group by 58% (95% CI 49 to 66%).
With the 3-day after admission criteria defining PC exposure (n=41), average daily costs were not much affected by the different grouping, but total costs shifted in favor of PCoverall costs were e.g. reduced by CHF 14'461 (5'203 to 25'721) in PC compared to UC; in the main analysis the groups were closer together. The main drivers for this difference were surgery, ward and staff costs, which were all shifted in favor of PC (appendix VI-VII).
Discussion
Our analysis suggests that PC reduces average daily costs but may not reduce total costs as patients stayed longer. A reduction of average daily costs by PC has been observed before. 3, [5] [6] [7] [11] [12] [13] 15 but may not be as significant for policymakers than a reduction in total costs. A significant reduction of total costs was only seen when PC exposure was defined as 'referral to PC within 3 days from admission to the hospital'. The exposure chosen in our study (based on a 25% threshold on the exposure to PC) may explain why compared to international trends, 3, 4, 7, 9, 13, 15 total costs in our sample were not significantly lower for PC. In particular, long-stayers with high total costs who did not start PC right away may still be considered as receiving PC in our setting.
Individual cost components, which are significantly higher for PC compared to UC patients, are hotel (organizational unit), catering and room (cost types), as well as nursing, social counselling and therapist costs (staff detail). In contrast to lower cost components such as radiology, laboratory, material and pharmacy costs, the higher costs in PC for direct care such as nursing staff and therapists may be those that contribute to increased quality of care Like in many other developed countries, economic pressure also weighs on the Swiss healthcare sector. Therefore, hospitals increasingly have to justify their health offers, including whether and how PC contributes to in-hospital costs. 35, 37 Our in-depth approach can comprehensively show that the cost components of PC which are significantly higher are direct costs due to a longer hospital stay. However, length of stay in hospital depends largely on the availability of surrounding healthcare offers such as mobile home care teams and nursing homes. Thus, cost components driven by the length of stay are directly dependent on the possibility to transfer complex patients to another setting of care when patients are stable and which may not be regarded as valid factors/ measurements for cost evaluation studies in end of life and PC. Keeping a balance between the quality of care at the end of life and its incurred costs will be a challenging task for healthcare systems in the near future. 12 There are a number of limitations to our study. In particular, the generalizability of the results might be questioned. Data was collected from one University hospital and thus does not contain cost data from other health settings including other hospitals, hospices, as well as different hospital types such as private, non-profit and public hospitals. An international or inter-institutional comparison may provide a better basis to further understand the cost saving impact, as well as to support discussions between stakeholders, such as in reimbursement negotiations. In this case, an agreed set of cost components (leaving out components that are directly linked to length of stay) is needed as a common basis. Whether some types of cost data are preferable to others could be the focus of future studies.
Moreover, increasing the sample size by adding data from other years could have help increase power in our comparisons. To avoid bias, future research should also include all patients' discharges (alive and dead). 36 In addition, a prospective longitudinal design across settings of care may provide more comprehensive results. Costs in retrospective studies might appear higher because PC is added to conventional therapy. As an example, this study defined a PC patient as a patient who receives PC on the PC ward or a PC consultation only. However, we did not distinguish between both interventions. Another limitation might be the potential self-selection bias, which "arises when a rule other than simple random sampling is used to sample the underlying population", 37 however, we tried to reduce this problem using simple exclusion criteria. With respect to the study's statistical methodology, propensity-score weighting might fail to adjust adequately for unmeasured variables and we only measured a limited set of confounders. Psychosocial factors and unobserved complications in a patient's condition throughout the hospital stay may also affect the cost estimates. However, we tried to provide a valid comparison between PC and UC patients using all available data at the time of hospital admission. 16 The development of the cost matrix can be questioned but the data from the accounting system leave little room for cost allocation varieties. The advantage of this matrix is the option to analyze individual costs blocks separately (e.g. only ward costs). The correlation of costs and quality of care needs to be discussed in further research. Finally, the definition of PC based on a 25% threshold on the exposure to PC may have led to the dilution of the sample by patients that did not profit from the PC intervention, including long-stayers with high total costs. Other authors 17, 35 have employed referral within a few days from admission as adequate timeframes, which have shown that the earlier the exposure the greater the chances of positive impacting on cost. Indeed, such an approach favored the PC group in our analysis with respect to total costs.
Conclusion
We contribute to the growing literature a comprehensive analysis of hospital cost components from three different perspectives: (1) organizational units (2) cost types and (3) staff detail. We identified main triggers that influence the cost components in PC and UC patients, which can be the basis for comprehensive and reliable cost analyses. Such analysis enhances transparency for internal and external stakeholders and can serve as a potential controlling instrument. The recognition of these differences between and within costs can be an advantage to justify health offers in financially tense healthcare industries in the future. Grey marked fields represent cost components already analyzed in previous studies ( Table 2) .
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